We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: New oral cancer brush test diagram (Teh, MT., Patil, R., Tekade, S.A. et al. Biomark Research, 2026. https://doi.org/10.1186/s40364-026-00963-7)

Rapid Brush Biopsy Test Detects Oral Cancer in One Hour

An oral brush molecular test detects oral cancer in one hour, reducing unnecessary biopsies. More...
08 Jul 2026
Image: Traditional vs. Biomarker-Based Methods for Colorectal Cancer (CRC) Detection. Traditional CRC detection methods such as colonoscopy, stool-based test (FIT & FOBT), and CT colonography are depicted above. Below, emerging biomarker-based approaches including genomics, gut microbiome, and metabolomic and proteomic profiles are illustrated. (Reem A. Qannita et al., Clinica Chimica Acta, 2026. DOI: 10.1016/j.cca.2026.121013

Noninvasive Biomarkers Advance Colorectal Cancer Risk Assessment

New findings highlight minimally invasive ctDNA and miRNA biomarkers that improve early colorectal cancer detection. More...
08 Jul 2026
Image: A new computational framework makes genomic surveillance faster and more cost-effective for emerging COVID-19 strains (Image Credit: 123RF)

Genomic Surveillance Algorithm Improves Early Detection of Emerging Variants

A new algorithmic framework for global genomic surveillance speeds variant detection and cuts costs. More...
08 Jul 2026
Image

AI-Driven Blood Test Enhances Early Detection of Multiple Cancers

A new blood test using ultra-deep whole-genome and transcriptome sequencing plus AI improves early multi-cancer signal detection. More...
08 Jul 2026
Image: Traditional vs. Biomarker-Based Methods for Colorectal Cancer (CRC) Detection. Traditional CRC detection methods such as colonoscopy, stool-based test (FIT & FOBT), and CT colonography are depicted above. Below, emerging biomarker-based approaches including genomics, gut microbiome, and metabolomic and proteomic profiles are illustrated. (Reem A. Qannita et al., Clinica Chimica Acta, 2026. DOI: 10.1016/j.cca.2026.121013

Noninvasive Biomarkers Advance Colorectal Cancer Risk Assessment

New findings highlight minimally invasive ctDNA and miRNA biomarkers that improve early colorectal cancer detection. More...
08 Jul 2026
Image: The study found that patients with detectable postsurgical ctDNA had markedly better outcomes with adjuvant chemotherapy than without it (Image Credit: Adobe Stock)

Blood Test Helps Guide Post-Surgical Treatment in Metastatic Colorectal Cancer

A new ctDNA test identifies post-surgery colorectal liver metastasis patients who benefit from adjuvant chemotherapy. More...
07 Jul 2026
Image: Primary central nervous system lymphoma (PCNSL) is a rare malignancy of the brain, spinal cord, and eyes that is often diagnosed late and associated with poor outcomes (Photo courtesy of Tdvorak / Wikimedia Commons / CC BY-SA 3.0)

EBV Status Helps Predict Survival in Primary CNS Lymphoma

A new study identifies a three-factor outcome model for immune-related primary CNS lymphoma. More...
07 Jul 2026
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
PURITAN MEDICAL